Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Shares Issued (2018 - 2025)

TELA Bio (TELA) has 8 years of Shares Issued data on record, last reported at $45000.0 in Q3 2025.

  • For Q3 2025, Shares Issued fell 18.18% year-over-year to $45000.0; the TTM value through Sep 2025 reached $50000.0, up 100.11%, while the annual FY2024 figure was $226000.0, 77.95% up from the prior year.
  • Shares Issued reached $45000.0 in Q3 2025 per TELA's latest filing, down from $59000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $46.3 million in Q2 2023 and bottomed at -$46.2 million in Q4 2023.
  • Average Shares Issued over 5 years is $700277.8, with a median of $44500.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: tumbled 25582.35% in 2022, then soared 925900.0% in 2023.
  • A 5-year view of Shares Issued shows it stood at $136000.0 in 2021, then crashed by 25582.35% to -$34.7 million in 2022, then tumbled by 33.35% to -$46.2 million in 2023, then surged by 99.88% to -$55000.0 in 2024, then surged by 181.82% to $45000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $45000.0 in Q3 2025, $59000.0 in Q2 2025, and $1000.0 in Q1 2025.